Cresco Labs (CRLBF) Change in Receivables (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Change in Receivables came in at -$406000.0 in Q1 2026, down 105.96% YoY from $6.8 million in Q1 2025, and up 98.06% on a QoQ basis from -$20.9 million in Q4 2025.
Cresco Labs (CRLBF) Change in Receivables (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Change in Receivables data on file, last reported at -$406000.0 in Q1 2026.
- Quarterly Change in Receivables fell 105.96% year-over-year to -$406000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.2 million (down 392.58% YoY) and the FY2025 annual result came in at -$12.0 million, down 795.32% from the prior year.
- Change in Receivables advanced to -$406000.0 in Q1 2026, from -$20.9 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $14.2 million in Q4 2023 to a low of -$20.9 million in Q4 2025.
- A 5-year average of -$1.2 million and a median of -$1.4 million in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 380.0% — and 2025, when it slumped 472.32%.
- Tracing CRLBF's Change in Receivables over 5 years: stood at -$5.1 million in 2022, then soared by 380.0% to $14.2 million in 2023, then tumbled by 60.45% to $5.6 million in 2024, then tumbled by 472.32% to -$20.9 million in 2025, then surged by 98.06% to -$406000.0 in 2026.
- The last three Change in Receivables figures came in at -$406000.0 (Q1 2026), -$20.9 million (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | -3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -406,000.00 |
| Mar 31, 2026 | -406,000.00 |
| Dec 31, 2025 | -20.90 Mn |
| Dec 31, 2025 | -20.90 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.73 Mn |
| Mar 31, 2025 | 6.81 Mn |
| Mar 31, 2025 | 6.81 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Dec 31, 2024 | 5.61 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -4.43 Mn |
| Jun 30, 2024 | -4.43 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 14.20 Mn |
| Dec 31, 2023 | 14.20 Mn |